WO2026018141 - A STABLE READY TO USE SUSPENSION OF EMPAGLIFLOZIN
National phase entry is expected:
Publication Number
WO/2026/018141
Publication Date
22.01.2026
International Application No.
PCT/IB2025/057104
International Filing Date
14.07.2025
Title **
[English]
A STABLE READY TO USE SUSPENSION OF EMPAGLIFLOZIN
[French]
SUSPENSION STABLE PRÊTE À L'EMPLOI D'EMPAGLIFLOZINE
Applicants **
CALLIDUS RESEARCH LABORATORIES PRIVATE LIMITED.
Inventors
BHADGALE, Mahesh
BAFNA, Vardhaman
Priority Data
202421053964
15.07.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1954 | |
| EPO | Filing, Examination, Granting | 11565 | |
| Japan | Filing, Examination, Granting | 1985 | |
| South Korea | Filing, Examination, Granting | 1719 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
21,963
Contact Us
Abstract[English]
The present invention relates to a stable ready to use suspension of empagliflozin Particularly, the present invention relates to a stable, taste-masked, ready to use suspension of empagliflozin and the process for preparing it. The present invention also relates to a method for treating patients with diabetes, type 1 or type 2 by administering a stable, taste-masked, ready-to-use suspension comprising empagliflozin and pharmaceutically acceptable excipients.[French]
La présente invention concerne une suspension stable prête à l'emploi d'empagliflozine. En particulier, la présente invention concerne une suspension stable, à goût masqué, prête à l'emploi d'empagliflozine et son procédé de préparation. La présente invention concerne également une méthode de traitement de patients atteints de diabète, de type 1 ou de type 2, par administration d'une suspension stable, à goût masqué, prête à l'emploi comprenant de l'empagliflozine et des excipients pharmaceutiquement acceptables.